Tech Company Financing Transactions
Seachaid Pharmaceuticals Funding Round
On 6/30/2014, Seachaid Pharmaceuticals landed $3.2 million in financing from Aisling Capital.
Transaction Overview
Company Name
Announced On
6/30/2014
Transaction Type
Venture Equity
Amount
$3,230,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
801 Capitola Dr. 5
Durham, NC 27713
USA
Durham, NC 27713
USA
Phone
Website
Email Address
Not Recorded
Overview
Seachaid Pharmaceuticals is a clinical stage company committed to the discovery and development of new therapeutics to treat human diseases. Our chief aim is to produce step down therapies that will enable patients to leave the hospital earlier and complete their medicinal regimens in the comfort and convenience of their own homes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Elms
Vice President
Kenneth James
VP - Bus. Development
Radha Krishnan
Browse more venture capital transactions:
Prev: 6/30/2014: Athos venture capital transaction
Next: 6/30/2014: Thrive Networks venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs